Study of β-thymosins in Scleroderma Patients with Lung Disease
Author Information
Author(s): De Santis Maria, Inzitari Rosanna, Bosello Silvia L, Peluso Giusy, Fanali Chiara, Iavarone Federica, Zizzo Gaetano, Bocci Mario, Cabras Tiziana, Messana Irene, Fuso Leo, Varone Francesco, Pagliari Gabriella, Castagnola Massimo, Ferraccioli Gianfranco
Primary Institution: Catholic University, Rome, Italy
Hypothesis
The study aims to investigate the presence of thymosins β4, β4 sulfoxide, and β10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and their relation to pulmonary parameters.
Conclusion
Higher levels of thymosin β4 in scleroderma patients may have a protective role against lung tissue damage.
Supporting Evidence
- Thymosin β4 levels were significantly higher in scleroderma patients than in controls.
- Higher thymosin β4 levels seem to have a protective role against lung tissue damage.
- Thymosin β4 sulfoxide levels were higher in smokers and in scleroderma patients with alveolitis.
Takeaway
This study looked at special proteins in the lungs of people with a disease called scleroderma, finding that one of these proteins might help protect their lungs.
Methodology
The study used Reverse Phase-High Performance Liquid Chromatography-Electrospray-Mass Spectrometry to analyze bronchoalveolar lavage fluid from 46 scleroderma patients and 15 controls.
Limitations
The study is limited by its sample size and the need for further validation in larger cohorts.
Participant Demographics
46 scleroderma patients (mean age 55.1 years, 78.3% female) and 15 control subjects (mean age 60.0 years, 60.0% female).
Statistical Information
P-Value
0.008
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website